PhotoCure - Report for 2001
Oslo, 27 February 2002.PhotoCure ASA (Oslo Stock Exchange: PHO) presents today the report with the results for 2001. The main items of the report are:- Metvix® approvedMetvix® PDT was approved in Sweden and later recognised in large parts of Europe. In February 2002, the product was also approved in New Zealand. Moreover, marketing authorisation applications for Metvix® have also been filed in the US, Australia and Switzerland.- Marketing and cooperation agreement signed with Galderma S.A.PhotoCure has given Galderma exclusive global marketing rights to both the Metvix® cream and